• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

An experimental study on the control of bronchial asthma by a regenerating factor of bronchial epithelial cells

Research Project

Project/Area Number 13670592
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionThe University of Tokyo

Principal Investigator

DOHI Makoto  The University of Tokyo, Health Service Center, Research Associate, 保健管理センター, 助手 (60222155)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Kazuhiko  The University of Tokyo, Allergy and Rheumatology, Professor, 医学部附属病院, 教授 (80191394)
TANAKA Ryoichi  The University of Tokyo, Allergy and Rheumatology, Research Associate, 医学部附属病院, 助手 (60272556)
Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2002: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2001: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsBronchial asthma / Hepatocyte growth factor / Repair factor / 動物モデル / 気道過敏性 / 気管支上皮細胞 / 気道炎症 / 肝細胞増殖因子(MGF)
Research Abstract

We investigated a role of hepatocyte growth factor (HGF) in bronchial asthma with experimental model.
1) Serial change in serum HGF expression
BALD/c mice were immunized with ovalubmin (OVA) antigen, then were nebulized with OVA solution. to induce asthmatic response. HGF concentration in. the lung and serum were serially measured. Systemic sensitization with antigen induced an increase in lung HGF content. Along with the development of airway inflammation, HGF content further increased.
2) Study on the induction of HGF-producing plasmid vector in vivo
First, intra-muscular injection of the plasmid failed to produce HGF protein. Next we injected the plasmid with cationic liposome directly in the lung. Although certain amount of HGF was measurable in lung extract by this route of injection, it provoked non-specific inflammation in the lung, and neutrophils infiltrated into the lung. So this method would not be applicable for humans. Next, intra-dermal injection was tried, but it did not produce HGF expression.
As a forth trial, we applied intravenous administration of the plasmid. This achieved a high serum HGF concentration of 50〜80 ng/ml, and the increase in serum concentration continued for 5 about days.
3) Finally, we investigated a role of HGF in vivo in a mouse model of asthma by intravenous injection system. BALB/c mice were immunized with.ovalubmin OVA, then were nebulized with OVA solution for 3 consecutive days. Twenty four hours after the final inhalation, samples were analyzed. HGF-producing vector or control vector was administered before the first OVA inhalation by a single injection. Induction of HGF-producing vector in vivo suppressed the increase in airway hyperreactivity as well as eosinophilic airway inflammation. These results, for the first time, clarified an inhibitory role of HGF in allergic reaction in the airway. For further progress analyses of the mechanisms of the suppression should be investigated.

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] Y.To, M.Dohi, K.Matsumoto et al.: "A two way interaction between hepatocyte growth factor and interleukin-6 in tissue invasin of lung cancer cell line"Am.J.Respir Cell Mol.Biol.. 27. 220-226 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] To Y, Dohi M, Matsumoto K, Tanaka R, Sato A, Nakgome K, Nakamura T, Yamamoto K.: "A two way interaction between hepatocyte growth factor, and interkeukm-6 in tissue invasion of lung cancer cell line."Am.J.Respir.Cell Mol.Biol. 27. 220-226 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] To Y, Dohi M, Matsumoto K, et al.: "A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line"Am. J.Respir.Cell Mol.Biol.. 27(2). 220-226 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takami K., Takuma N., Dohi M., et al.: "Interferon-gamma inhibits hepatocyte-growth factor-stimulated cell proliferation of human bronchial epithelial cells"Am J. Respir Cell Mol Biol. 26. 231-238 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] To Y., Dohi M., Tanaka R., et al.: "Early in terleukin-4 dependent response can induce airway hyperreactivity before development of airway inflammation"Lab. Invest. 81. 2385-2396 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Dohi M., Hasegawa T., Yamamoto K., et al.: "Hepatocyte growth factor attenuates collayen accumulation in a murine model of pulmonary fibrosis"Am J Respir Crit Care Med. 162. 2302-2307 (2000)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi